Subscriptions & Products
Subscription to The Medical Letter On Drugs and Therapeutics
The Medical Letter is a biweekly publication that provides:
- Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts
- New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings
- Consensus recommendations for the preferred and alternative treatments for common disorders
- Comparative reviews of all of the drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
- An occasional review of a new non-drug treatment or a new diagnostic aid
- Up to 52 CME credits per year – online or on your mobile device, including ABIM MOC points
Reader Testimonials
The Medical Letter is a "treasure" In my view the ML is a "treasure". For a relatively small cost, we have access to unbiased reviews of new drugs, as well as reviews of drug classes.. This subscription is a "no brainer". ... More Submitted by A. Adinoff Very useful summary I wish to commend the author(s) of Issue No. 1518. It is an excellent example of what I find most helpful: It is beautifully organized for a nephrologist like me. It gives a very useful summary of the approach to drug therapy of COPD. Instead of emphasizing details about each drug, it provides an overview of how drugs are employed in therapy. It made sense for me in an area with which I am not very familiar. Overall I was left with an approach to therapy of the patient. Congratulations!... More Submitted by R. Maffly |
